GATM
Glycine amidinotransferase, mitochondrial
Also known as: AGAT, GATM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50440
- Gene
- GATM
- Ensembl
- ENSG00000171766
- Chromosome
- 15
- Canonical length
- 423 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a mitochondrial enzyme that belongs to the amidinotransferase family. This enzyme is involved in creatine biosynthesis, whereby it catalyzes the transfer of a guanido group from L-arginine to glycine, resulting in guanidinoacetic acid, the immediate precursor of creatine. Mutations in this gene cause arginine:glycine amidinotransferase deficiency, an inborn error of creatine synthesis characterized by cognitive disability, language impairment, and behavioral disorders. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
423 residues, UniProt reviewed canonical sequence.
>P50440|GATM
1 MLRVRCLRGG SRGAEAVHYI GSRLGRTLTG WVQRTFQSTQ AATASSRNSC AADDKATEPL
61 PKDCPVSSYN EWDPLEEVIV GRAENACVPP FTIEVKANTY EKYWPFYQKQ GGHYFPKDHL
121 KKAVAEIEEM CNILKTEGVT VRRPDPIDWS LKYKTPDFES TGLYSAMPRD ILIVVGNEII
181 EAPMAWRSRF FEYRAYRSII KDYFHRGAKW TTAPKPTMAD ELYNQDYPIH SVEDRHKLAA
241 QGKFVTTEFE PCFDAADFIR AGRDIFAQRS QVTNYLGIEW MRRHLAPDYR VHIISFKDPN
301 PMHIDATFNI IGPGIVLSNP DRPCHQIDLF KKAGWTIITP PTPIIPDDHP LWMSSKWLSM
361 NVLMLDEKRV MVDANEVPIQ KMFEKLGITT IKVNIRNANS LGGGFHCWTC DVRRRGTLQS
421 YLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GATM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 2,768 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 2,768 nTPM
- liver: 2,621 nTPM
- kidney: 1,960 nTPM
- spinal cord: 208 nTPM
- duodenum: 165 nTPM
- amygdala: 142 nTPM
Single-cell type
- hepatocytes: 1,860 nCPM
- pancreatic acinar cells: 1,025 nCPM
- granulosa cells: 630 nCPM
- gastric chief cells: 222 nCPM
- cholangiocytes: 218 nCPM
- epididymal efferent duct absorptive cells: 193 nCPM
Immune cell
- memory B-cell: 11 nTPM
- plasmacytoid DC: 6.8 nTPM
- myeloid DC: 6.6 nTPM
- naive B-cell: 5.4 nTPM
- intermediate monocyte: 1.6 nTPM
- naive CD8 T-cell: 1.4 nTPM
Brain region
- white matter: 200 nTPM
- medulla oblongata: 147 nTPM
- cerebellum: 146 nTPM
- spinal cord: 138 nTPM
- pons: 137 nTPM
- hypothalamus: 123 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GATM.
Disease | AllUniProt
Conditions GATM is implicated in, by any mechanism.
- Cerebral creatine deficiency syndrome 3 (CCDS3) MIM:612718
- Fanconi renotubular syndrome 1 (FRTS1) MIM:134600
Disease | GeneticClinVar
38 pathogenic / likely-pathogenic of 668 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arginine:glycine amidinotransferase deficiency
- Fanconi renotubular syndrome 1
- Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 2.29
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- creatine biosynthetic process
- creatine metabolic process
- learning or memory
- muscle atrophy
- positive regulation of cold-induced thermogenesis
Molecular functions
- amidinotransferase activity
- glycine amidinotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycine/inosamine-phosphate amidinotransferase-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GATM as an antibody target. Whether an autoantibody or antibody against GATM could matter depends on whether native GATM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GATM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GATM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...